ArticleBlood2023

The orally bioavailable GSPT1/2 degrader SJ6986 exhibits in vivo efficacy in acute lymphoblastic leukemia.

Yunchao Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.